While PSMA PET/CT has emerged as a valuable imaging modality for PCa, particularly in initial staging, detection of biochemical relapse, and guidance of targeted therapy, its widespread clinical adoption remains limited. Here, FOLH1 is linked to posterior cortical atrophy.